Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Clinical trial NCT00085813 · COMPLETED

Trial details

NCT number: NCT00085813
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small-Cell Lung Cancer

Start date: 2003-12-01
Primary completion: 2005-10-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.